Abstract
Retroviral vectors derived from lentiviruses such as HIV-1 are promising tools for human gene therapy because they mediate the in vivo delivery and long-term expression of transgenes in nondividing tissues. We describe an HIV vector system in which the virulence genes env, vif, vpr, vpu, and nef have been deleted. This multiply attenuated vector conserved the ability to transduce growth-arrested cells and monocyte-derived macrophages in culture, and could efficiently deliver genes in vivo into adult neurons. These data demonstrate the potential of lentiviral vectors in human gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mulligan, R.C. 1993. The basis science of gene therapy. Science 260: 926–932.
Crystal, R.G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270: 404–410.
Leiden, J.M. 1995. Gene therapy—promises, pitfalls and prognosis. N. Engl. J. Med. 333: 871–873.
Sanders, W.R. 1995. Human gene therapy—of tortoises and hares. Nature Medicine 1: 1137–1138.
Roe, T., Reynolds, T.C., Yu, G., and Brown, P.O. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12: 2099–2108.
Lewis, P.F. and Emerman, M. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68: 510–516.
Lewis, P., Hensel, M., and Emerman, M. 1992. Human immunodeficiency virus infection of cell arrested in the cell cycle. EMBO J. 11: 3053–3058.
Bukrinsky, M.I., Haggerty, S., Dempsey, M.P., Sharova, N., Adzhubei, A., Spitz, L., et al. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365: 666–669.
von Schwedler, U., Kornbluth, R.S., and Trono, D. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91: 6992–6996.
Gallay, P., Stitt, V., Mundy, C., Oettinger, M., and Trono, D. 1996. Role of the karyopherin pathway in human immunodeficiency type 1 nuctear import. J. Virol. 70: 1027–1032.
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R.C., Gage, F.H., et al. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263–267.
Naldini, L., Blömer, U., Gage, F.H., Trono, D. and Verma, I.M. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl Acad. Sci. USA 93: 11382–11388.
Trono, D. 1995. HIV accessory proteins: leading role for the supporting cast. Cell 82: 189–192.
Miller, R.H. and Sarver, N. 1997. HIV accessory proteins as therapeutic targets. Nature Medicine 3: 389–394.
Gheysen, D. et al. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59: 103–112.
Heinzfriger, N.K., Bukrinsky, M.I., Haggerty, S.A., Ragland, A.M., Kewalramani, V., Lee, M.A., et al. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuctear localization of viral nudefc acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91: 7311–7315.
Gabuzda, D.H., Lawrence, K., Langhoff, E., Terwilliger, E.F., Dorfman, T., Haseltine, W.A., et al. 1992. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 66: 6489–6495.
von Schwedler, U., Song, J., Aiken, C., and Trono, D. 1993. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67: 4945–4955.
Klimkait, T., Strebel, K., Hoggan, M.D., Martin, M.A., and Orenstein, J.M. 1990. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64: 621–629.
Göttlinger, H.G., Dorfman, T., Cohen, E., and Haseltine, W.A. 1993. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA 90: 7381–7385.
Miller, M.D., Warmerdam, M.T., Gaston, I., Greene, W.C., and Feinberg, M.B. 1994. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179: 101–113.
Spina, C.A., Kwoh, T.J., Chowers, M.Y., Guatelli, J.C., and Richman, D.D. 1994. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179: 115–123.
Aiken, C. and Trono, D. 1995. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69: 5048–5056.
Schwartz, O., Marechal, V., Danos, O., and Heard, J.-M. 1995. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69: 4053–1059.
Chowers, M.Y., Pandori, M.W., Spina, C.A., Richman, D.D., and Guatelli, J.C. 1995. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212: 451–457.
Aiken, C. 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71: 5871–5877.
Gallay, P., Chin, D., Hope, T.J., and Trono, D. HIV-1 infection of nondividing cells mediated through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA. In press.
Levy, D.N., Fernandes, L.S., Williams, W.V., and Weiner, D.B. 1993. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72: 541–550.
Rogel, M.E., Wu, L.I., and Emerman, M. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69: 882–888.
Kirchhoff, F., Greenough, T.C., Brettler, D.B., Sullivan, J.L., and Desrosiers, R.C. 1995. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332: 228–232.
Deacon, N.J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D.J., et al. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270: 988–991.
Kestler, H.W. III, Ringler, D.J., Mori, K., Panicali, D.L., Sehgal, P.K., Daniel, M.D., et al. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651–662.
Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K., and Desrosiers, R.C. 1992. Protective effect of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 258: 1938–1941.
Wyand, M.S., Manson, K.H., Lackner, A.A., and Desrosiers, R.C. 1997. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nature Medicine 3: 32–36.
Gibbs, J.S., Regier, D.A., and Desrosiers, R.C. 1994. Construction and in vitro properties of SIVmac mutants with deletions in “nonessential” genes. AIDS Res. Hum. Retrovir. 10: 607–616.
Park, I.-W., Myrick, K., and Sodroski, J. 1994. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus. J. AIDS 7: 1228–1236.
Lang, S.M., Strahl-Hennig, C., Coulibaly, C., Hunsmann, G., Muller, J., Muller-Hermalink, H., et al. 1993. Importance of vpr for infection of rhesus monkey with simian immunodeficiency virus. J. Virol. 67: 902–912.
Fletcher, T.M., Brichacke, B., Sharova, N., Newman, M.A., Stivahtis, G., Sharp, P.M., et al. 1997. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV. EMBO J. 15: 6155–6165.
Wang, B., Ge, Y.C., Palasanthiran, P., Xiang, S., Ziegler, J., Dwyer, D.E., et al. 1996. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispcies in blood and plasma. Virology 223: 224–232.
Brach, M.A., Hass, R., Sherman, M.L., Gunji, H., Weichselbaum, R., and Kufe, D. 1991. Ionizing radiation induces expression and binding activity of the Nuclear Factor κB. J. Clin. Invest. 88: 691–695.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zufferey, R., Nagy, D., Mandel, R. et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15, 871–875 (1997). https://doi.org/10.1038/nbt0997-871
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0997-871
This article is cited by
-
Development of a pseudo-typed virus particle based method to determine the efficacy of virucidal agents
Scientific Reports (2024)
-
A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9
npj Vaccines (2023)
-
Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Orphanet Journal of Rare Diseases (2023)
-
RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation
Acta Neuropathologica (2023)
-
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
Nature Biomedical Engineering (2023)